Physical Activity and Education for Colorectal Cancer
(CHALLENGE Trial)
Trial Summary
What is the purpose of this trial?
RATIONALE: Participating in a physical activity program designed to increase free time physical activity and receiving written health education materials may influence the chance of cancer recurring as well as impact on physical fitness, psychological well-being and the quality of life of patients who have undergone surgery and chemotherapy for colon cancer. It is not yet known whether giving a physical activity program together with health education materials is more effective than giving health education materials alone for patients who have undergone colon cancer treatment. PURPOSE: This randomized phase III trial is studying a physical activity program given together with health education materials to see how well it works compared with giving health education materials alone for patients who have undergone treatment for high-risk stage II or stage III colon cancer.
Research Team
Janette Vardy, PhD, FRACP
Principal Investigator
Sydney Cancer Centre at Concord Repatriation General Hospital
Kerry Courneya, PhD
Principal Investigator
University of Alberta
Christopher Booth, MD
Principal Investigator
Cancer Centre of Southeastern Ontario at Kingston General Hospital
Eligibility Criteria
This trial is for patients who've completed certain chemotherapy for high-risk stage II or III colon cancer within the last 60-180 days. They should be able to communicate, complete questionnaires and exercise tests, not meet current physical activity guidelines, and have no evidence of recurring cancer. Pregnant individuals or those planning pregnancy in the next 3 years are excluded.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Health Education Materials (Behavioral Intervention)
- Physical Activity Program (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Canadian Cancer Trials Group
Lead Sponsor
Dr. Janet Dancey
Canadian Cancer Trials Group
Chief Medical Officer since 2014
MD, FRCPC
Susan Marlin
Canadian Cancer Trials Group
Chief Executive Officer since 2012
BSc (Hons) from Dalhousie University, MSc in Community Health and Epidemiology from Queen’s University
Queen's University, Belfast
Collaborator
Professor Sir Ian Greer
Queen's University, Belfast
Chief Executive Officer since 2018
MD from the University of Glasgow
Dr. Joann
Queen's University, Belfast
Chief Medical Officer since 2023
PhD in Molecular Pharmacology
Survivorship Research Group
Collaborator